CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Camp4 Therapeutics Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$3.14−0.03 (-0.95%)
Close on Oct 19, 2026
- Market cap
- $181.90M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
66.5%
42M of 63M shares
Institutional holders
61
23 new, 7 sold out
Net institutional buying
8M
In Q2 2026
Insider trades, 12 months
5 buys · 6 sales
Net sold $2.40M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Andrew J. Schwab | 6,379,125 | 9.90% | 13D (active) amendment | Aug 27, 2026 |
| Janus Henderson Group PLC | 6,307,636 | 12.20% | 13G (passive) | Dec 31, 2025 |
| Kush Parmar | 5,869,091 | 12.50% | 13D (active) amendment | Sep 9, 2025 |
| Abigail P. Johnson | 4,918,243 | 9.50% | 13G (passive) amendment | Dec 31, 2025 |
| Coastlands Capital LP | 4,886,722 | 10.00% | 13G (passive) | Sep 10, 2025 |
| Matthew D. Perry | 4,886,722 | 9.99% | 13G (passive) amendment | Sep 10, 2025 |
| Amir Nashat | 3,932,251 | 6.30% | 13D (active) amendment | Aug 13, 2026 |
| Vivo Opportunity Fund Holdings, L.P. | 3,856,991 | 7.40% | 13G (passive) amendment | Dec 31, 2025 |
| Trails Edge Biotechnology Master Fund, LP | 3,790,636 | 6.00% | 13G (passive) | Aug 3, 2026 |
| FMR LLC | 3,023,434 | 15.00% | 13G (passive) | Sep 30, 2025 |
| Bam Gp LLC | 2,632,437 | 5.07% | 13G (passive) | Mar 31, 2026 |
| HarbourVest Partners, LLC | 1,271,948 | 6.30% | 13G (passive) | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CAMP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 6,307,636 | 10.05% | $27.58M | New | 0.01% |
| 5AM Venture Management, LLC | 5,869,091 | 9.35% | $25.65M | – | 8.91% |
| FMR LLC | 4,904,339 | 7.82% | $21.43M | −29,093 | 0.00% |
| Vivo Capital, LLC | 4,246,568 | 6.77% | $18.56M | – | 1.69% |
| Balyasny Asset Management L.P. | 2,575,724 | 4.10% | $11.26M | −56,713 | 0.01% |
| a16z Capital Management, L.L.C. | 2,125,339 | 3.39% | $9.29M | – | 0.07% |
| Adage Capital Partners Gp, L.L.C. | 1,960,784 | 3.12% | $8.57M | – | 0.01% |
| Trails Edge Capital Partners, LP | 1,932,937 | 3.08% | $8.45M | −6,626 | 1.34% |
| BlackRock, Inc. | 1,644,134 | 2.62% | $7.18M | +1,187,763 | 0.00% |
| Vanguard Capital Management LLC | 1,533,489 | 2.44% | $6.70M | −1,279 | 0.00% |
| Enavate Sciences Gp, LLC | 1,425,541 | 2.27% | $6.23M | −765,379 | 1.80% |
| Stonepine Capital Management, LLC | 1,389,622 | 2.21% | $6.07M | – | 3.43% |
| HarbourVest Partners LLC | 1,271,948 | 2.03% | $5.56M | – | 3.27% |
| Geode Capital Management, LLC | 795,651 | 1.27% | $3.48M | +412,830 | 0.00% |
| SummitTX Capital, L.P. | 725,160 | 1.16% | $3.17M | +385,639 | 0.08% |
| Silverarc Capital Management, LLC | 653,594 | 1.04% | $2.86M | – | 0.30% |
| State Street Corp | 362,300 | 0.58% | $1.58M | +215,400 | 0.00% |
| Northern Trust Corp | 248,673 | 0.40% | $1.09M | +178,007 | 0.00% |
| Goldman Sachs Group Inc | 241,393 | 0.38% | $1.05M | +163,048 | 0.00% |
| Vanguard Fiduciary Trust Co | 226,074 | 0.36% | $987.94K | +31,061 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 61 | 42M | 66.5% | 23 / 15 | 12 / 7 | 10M | 2M |
| Q1 2026 | 46 | 40M | 63.4% | 14 / 15 | 9 / 7 | 5M | 2M |
| Q4 2025 | 40 | 38M | 60.9% | 13 / 11 | 10 / 2 | 12M | 2M |
| Q3 2025 | 29 | 28M | 45.0% | 8 / 4 | 11 / 8 | 17M | 0M |
| Q2 2025 | 29 | 12M | 18.7% | 7 / 6 | 11 / 17 | 0M | 1M |
| Q1 2025 | 39 | 13M | 20.2% | 7 / 11 | 11 / 4 | 0M | 0M |
| Q4 2024 | 36 | 13M | 20.5% | 36 / 0 | 0 / 0 | 13M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CAMP | Value | % of fund | As of |
|---|---|---|---|---|---|
| Select Biotechnology Portfolio | 1,326,208 | 2.11% | $5.82M | 0.11% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 1,139,169 | 1.82% | $4.98M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 453,046 | 0.72% | $1.98M | 0.00% | Jun 30, 2026 |
| Fidelity Growth Company Fund | 400,071 | 0.64% | $1.76M | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 357,195 | 0.57% | $1.56M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 341,836 | 0.54% | $1.18M | 0.00% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 267,733 | 0.43% | $1.17M | 0.01% | Jun 30, 2026 |
| Victory Science & Technology Fund | 226,602 | 0.36% | $781.78K | 0.05% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 165,086 | 0.26% | $724.73K | 0.00% | May 31, 2026 |
| Fidelity Growth Company K6 Fund | 109,513 | 0.17% | $480.76K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 103,784 | 0.17% | $453.54K | 0.03% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 76,660 | 0.12% | $264.48K | 0.00% | Jul 31, 2026 |
| Fidelity Series Growth Company Fund | 62,923 | 0.10% | $276.23K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 61,034 | 0.10% | $267.94K | 0.00% | May 31, 2026 |
| Victory RS Science & Technology Fund | 58,930 | 0.09% | $257.52K | 0.10% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Josh Mandel-Brehm | Chief Executive Officer, Director | 284,968 | 0.45% | Aug 5, 2026 |
| Kelly Gold | Chief Financial Officer | 86,467 | 0.14% | Sep 2, 2026 |
| Daniel Tardiff | Chief Scientific Officer | 0 | – | Aug 19, 2026 |
| Yuri Maricich | Chief Medical Officer | 12,611 | 0.02% | Aug 5, 2026 |
| David Bumcrot | Chief Scientific Officer | 61,741 | 0.10% | Apr 3, 2025 |
| Andrew J. Schwab | Director | 5,277,216 | 8.41% | Aug 31, 2026 |
| Richard A. Young | Director | 186,388 | 0.30% | Aug 5, 2026 |
| Murray Stewart | Director | – | – | Jun 12, 2026 |
| Douglas E. Williams | Director | 2,501 | 0.00% | Jun 12, 2026 |
| Steven H. Holtzman | Director | 108,946 | 0.17% | Jun 12, 2026 |
| Amir Nashat | Director, 10% owner | 197,661 | 0.31% | Jun 12, 2026 |
| Michael F. MacLean | Director | – | – | Apr 3, 2026 |
| Michael J. Higgins | Director | 28,739 | 0.05% | Jun 27, 2025 |
| Paula Ragan | Director | 20,232 | 0.03% | Jun 27, 2025 |
| James P. Boylan | Director | – | – | Jun 27, 2025 |
| Ravi I. Thadhani | Director | 17,014 | 0.03% | Jun 27, 2025 |
| 5AM Partners VII, LLC | 10% owner | – | – | Aug 5, 2026 |
| 5AM Opportunities II (GP), LLC | 10% owner | – | – | Aug 5, 2026 |
| 5AM Opportunities II, L.P. | 10% owner | 2,927,915 | 4.67% | Aug 5, 2026 |
| 5AM Partners VI, LLC | 10% owner | – | – | Aug 5, 2026 |
| 5AM Ventures VII, L.P. | 10% owner | 5,869,091 | 9.35% | Aug 5, 2026 |
| Kush Parmar | 10% owner | – | – | Aug 5, 2026 |
| 5AM Ventures VI, L.P. | 10% owner | – | – | Aug 5, 2026 |
| Polaris Partners GP X, L.L.C. | 10% owner | – | – | Sep 11, 2025 |
| Brian Chee | 10% owner | – | – | Sep 11, 2025 |
| Polaris Management Co. VII, L.L.C. | 10% owner | 2,825,500 | 4.50% | Sep 11, 2025 |
| Polaris Partners VII, L.P. | 10% owner | 1,603,779 | 2.56% | Sep 11, 2025 |
| Polaris Entrepreneurs' Fund VII, L.P. | 10% owner | – | – | Sep 11, 2025 |
| Amy W. Schulman | 10% owner | 909,090 | 1.45% | Sep 11, 2025 |
| Polaris Partners X, L.P. | 10% owner | 909,090 | 1.45% | Sep 11, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Kelly Gold Chief Financial Officer | Aug 31, 2026 | Buy | +10,000 | $3.96 | $39.60K | 10,000 |
| Andrew J. Schwab Director | Aug 27, 2026 | Sale | −400,000 | $4.04 | $1.62M | 2,033,270 |
| Andrew J. Schwab Director | Aug 24, 2026 | Sale | −10 | $4.50 | $45 | 2,433,270 |
| Andrew J. Schwab Director | Aug 21, 2026 | Sale | −32,018 | $4.50 | $144.08K | 2,433,280 |
| Andrew J. Schwab Director | Aug 20, 2026 | Sale | −114,700 | $4.54 | $520.74K | 2,465,298 |
| Andrew J. Schwab Director | Aug 19, 2026 | Sale | −45,147 | $4.76 | $214.90K | 2,579,998 |
| Daniel Tardiff Chief Scientific Officer | Aug 19, 2026 | Sale | −1,738 | $4.76 | $8.27K | 0 |
| Yuri Maricich Chief Medical Officer | Aug 3, 2026 | Buy | +6,551 | $1.65 | $10.81K | 12,611 |
| Josh Mandel-Brehm Chief Executive Officer, Director | Aug 3, 2026 | Buy | +6,551 | $1.65 | $10.81K | 284,968 |
| Richard A. Young Director | Aug 3, 2026 | Buy | +16,378 | $1.65 | $27.02K | 186,388 |
| Kelly Gold Chief Financial Officer | Aug 3, 2026 | Buy | +6,551 | $1.65 | $10.81K | 74,428 |
| 5AM Ventures VII, L.P. 10% owner | Sep 11, 2025 | Buy | +2,941,176 | $1.53 | $4.50M | 2,941,176 |
| Andrew J. Schwab Director, 10% owner | Sep 11, 2025 | Award | +2,941,176 | $1.53 | $4.50M | 2,941,176 |
| Polaris Management Co. VII, L.L.C. 10% owner | Sep 11, 2025 | Buy | +1,221,721 | $1.53 | $1.87M | 2,825,500 |
| Polaris Management Co. VII, L.L.C. 10% owner | Sep 11, 2025 | Buy | +85,468 | $1.53 | $130.77K | 197,661 |
| Amir Nashat Director, 10% owner | Sep 11, 2025 | Buy | +85,468 | $1.53 | $130.77K | 197,661 |
| Amir Nashat Director, 10% owner | Sep 11, 2025 | Buy | +1,221,721 | $1.53 | $1.87M | 2,825,500 |
| Kelly Gold Chief Financial Officer | Sep 11, 2025 | Buy | +6,060 | $1.65 | $10.00K | 67,877 |
| Richard A. Young Director | Sep 11, 2025 | Buy | +15,151 | $1.65 | $25.00K | 170,010 |
| Josh Mandel-Brehm Chief Executive Officer, Director | Sep 11, 2025 | Buy | +6,060 | $1.65 | $10.00K | 278,417 |
| Yuri Maricich Chief Medical Officer | Sep 11, 2025 | Buy | +6,060 | $1.65 | $10.00K | 6,060 |
| Polaris Management Co. VII, L.L.C. 10% owner | Oct 15, 2024 | Conversion | +24,745 | – | – | 112,193 |
| Polaris Management Co. VII, L.L.C. 10% owner | Oct 15, 2024 | Conversion | +353,718 | – | – | 1,603,779 |
| Polaris Management Co. VII, L.L.C. 10% owner | Oct 15, 2024 | Conversion | +87,448 | – | – | 87,448 |
| Polaris Management Co. VII, L.L.C. 10% owner | Oct 15, 2024 | Conversion | +1,250,061 | – | – | 1,250,061 |
| Polaris Management Co. VII, L.L.C. 10% owner | Oct 15, 2024 | Buy | +909,090 | $11.00 | $10.00M | 909,090 |
| AH Equity Partners Bio I, L.L.C. 10% owner | Oct 15, 2024 | Conversion | +1,398,067 | – | – | 1,398,067 |
| AH Equity Partners Bio I, L.L.C. 10% owner | Oct 15, 2024 | Buy | +545,454 | $11.00 | $6.00M | 545,454 |
| AH Equity Partners Bio I, L.L.C. 10% owner | Oct 15, 2024 | Buy | +181,818 | $11.00 | $2.00M | 1,579,885 |
| Northpond Ventures II, LP 10% owner | Oct 15, 2024 | Buy | +763,636 | $11.00 | $8.40M | 763,636 |
| Northpond Ventures II, LP 10% owner | Oct 15, 2024 | Conversion | +471,415 | – | – | 471,415 |
| Northpond Ventures II, LP 10% owner | Oct 15, 2024 | Conversion | +1,003,193 | – | – | 1,003,193 |
| Everest Aggregator, LP 10% owner | Oct 15, 2024 | Buy | +1,363,636 | $11.00 | $15.00M | 3,785,802 |
| Everest Aggregator, LP 10% owner | Oct 15, 2024 | Conversion | +2,422,166 | – | – | 2,422,166 |
| Polaris Partners VII, L.P. 10% owner | Oct 15, 2024 | Conversion | +353,718 | – | – | 1,603,779 |
| Polaris Partners VII, L.P. 10% owner | Oct 15, 2024 | Buy | +909,090 | $11.00 | $10.00M | 909,090 |
| Polaris Partners VII, L.P. 10% owner | Oct 15, 2024 | Conversion | +24,745 | – | – | 112,193 |
| Polaris Partners VII, L.P. 10% owner | Oct 15, 2024 | Conversion | +1,250,061 | – | – | 1,250,061 |
| Polaris Partners VII, L.P. 10% owner | Oct 15, 2024 | Conversion | +87,448 | – | – | 87,448 |
| Steven H. Holtzman Director | Oct 15, 2024 | Conversion | +8,917 | – | – | 108,946 |
| Richard A. Young Director | Oct 15, 2024 | Conversion | +8,917 | – | – | 154,859 |
| Josh Mandel-Brehm Chief Executive Officer, Director | Oct 15, 2024 | Conversion | +605 | – | – | 272,357 |
| Andrew J. Schwab Director, 10% owner | Oct 15, 2024 | Conversion | +1,337,592 | – | – | 1,337,592 |
| Andrew J. Schwab Director, 10% owner | Oct 15, 2024 | Buy | +909,090 | $11.00 | $10.00M | 2,625,145 |
| Andrew J. Schwab Director, 10% owner | Oct 15, 2024 | Conversion | +302,770 | – | – | 302,770 |
| Andrew J. Schwab Director, 10% owner | Oct 15, 2024 | Conversion | +378,463 | – | – | 1,716,055 |
| 5AM Opportunities II, L.P. 10% owner | Oct 15, 2024 | Buy | +909,090 | $11.00 | $10.00M | 2,625,145 |
| 5AM Opportunities II, L.P. 10% owner | Oct 15, 2024 | Conversion | +302,770 | – | – | 302,770 |
| 5AM Opportunities II, L.P. 10% owner | Oct 15, 2024 | Conversion | +1,716,055 | – | – | 1,716,055 |
| Amir Nashat Director, 10% owner | Oct 15, 2024 | Conversion | +24,745 | – | – | 112,193 |
| Amir Nashat Director, 10% owner | Oct 15, 2024 | Conversion | +1,250,061 | – | – | 1,250,061 |
| Amir Nashat Director, 10% owner | Oct 15, 2024 | Conversion | +87,448 | – | – | 87,448 |
| Amir Nashat Director, 10% owner | Oct 15, 2024 | Conversion | +353,718 | – | – | 1,603,779 |
| Amir Nashat Director, 10% owner | Oct 15, 2024 | Buy | +909,090 | $11.00 | $10.00M | 909,090 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Tardiff Daniel affiliate | Aug 19, 2026 | 1,738 | $8.28K | Aug 19, 2026 | 434 ESPP Issuance |